What mediates the benefits associated with dipeptidyl peptidase-IV inhibition?

被引：17

作者：

Ahrén, B ^{[1
]}

机构：

[1] Lund Univ, Dept Med, Lund, Sweden

[2] Univ Lund Hosp, Sect Endocrinol & Diabetol, S-22185 Lund, Sweden

来源：

DIABETOLOGIA | 2005年 / 48卷 / 04期

关键词：

D O I：

10.1007/s00125-005-1706-6

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

引用

收藏

页码：605 / 607

页数：3

相关论文

共 27 条

[1]

Autonomic regulation of islet hormone secretion -: Implications for health and disease [J].

Ahrén, B .

DIABETOLOGIA, 2000, 43 (04) :393-410

[2]

GLP-1 receptor agonists and DPP-4 inhibitors in the treatment of type 2 diabetes [J].

Ahrén, B ;

Schmitz, O .

HORMONE AND METABOLIC RESEARCH, 2004, 36 (11-12) :867-876

[3]

Inhibition of dipeptidyl peptidase-4 reduces glycemia, sustains insulin levels, and reduces glucagon levels in type 2 diabetes [J].

Ahrén, B ;

Landin-Olsson, M ;

Jansson, PA ;

Svensson, M ;

Holmes, D ;

Schweizer, A .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (05) :2078-2084

[4]

Sensory nerves contribute to insulin secretion by glucagon-like peptide-1 in mice [J].

Ahrén, B .

AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2004, 286 (02) :R269-R272

[5]

Twelve- and 52-week efficacy of the dipeptidyl peptidase IV inhibitor LAF237 in metformin-treated patients with type 2 diabetes [J].

Ahrén, B ;

Gomis, R ;

Standl, E ;

Mills, D ;

Schweizer, A .

DIABETES CARE, 2004, 27 (12) :2874-2880

[6]

Inhibition of dipeptidyl peptidase IV improves metabolic control over a 4-week study period in type 2 diabetes [J].

Ahrén, B ;

Simonsson, E ;

Larsson, H ;

Landin-Olsson, M ;

Torgeirsson, H ;

Jansson, PA ;

Sandqvist, M ;

Båvenholm, P ;

Efendic, S ;

Eriksson, JW ;

Dickinson, S ;

Holmes, D .

DIABETES CARE, 2002, 25 (05) :869-875

[7]

AHREN B, 2005, IN PRESS ENDOCRINOLO

[8]

Dual effects of pituitary adenylate cyclase-activating polypeptide and isoproterenol on lipid metabolism and signaling in primary rat adipocytes [J].

Åkesson, L ;

Ahrén, B ;

Manganiello, VC ;

Holst, LS ;

Edgren, G ;

Degerman, E .

ENDOCRINOLOGY, 2003, 144 (12) :5293-5299

[9]

Inhibitors of dipeptidyl peptidase IV:: a novel approach for the prevention and treatment of Type 2 diabetes? [J].

Deacon, CF ;

Ahrén, B ;

Holst, JJ .

EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2004, 13 (09) :1091-1102

[10]

Dipeptidyl peptidase IV inhibition potentiates the insulinotropic effect of glucagon-like peptide 1 in the anesthetized pig [J].

Deacon, CF ;

Hughes, TE ;

Holst, JJ .

DIABETES, 1998, 47 (05) :764-769